MARK2 and amyloidosis: It is well known that GSK-3β is a proline-directed serine/threonine kinase with structural activity, which enhances tau phosphorylation and regulates the amyloidosis of APP by regulating the expression of BACE and the function of gamma-secretase in vivo and in vitro [31].